Literature DB >> 26231094

Extracellular vesicles in lung microenvironment and pathogenesis.

Yu Fujita1, Nobuyoshi Kosaka2, Jun Araya3, Kazuyoshi Kuwano3, Takahiro Ochiya4.   

Abstract

Increasing attention is being paid to the role of extracellular vesicles (EVs) in various lung diseases. EVs are released by a variety of cells, including respiratory cells and immune cells, and they encapsulate various molecules, such as proteins and microRNAs, as modulators of intercellular communication. Cancer cell-derived EVs play crucial roles in promoting tumor progression and modifying their microenvironment. By contrast, noncancerous cell-derived EVs demonstrate protective functions against injury, such as tissue recovery and repair, to maintain physiological homeostasis. Airway cells in contact with harmful substances may alter their EV composition and modify the balanced reciprocal interactions with surrounding mesenchymal cells. We summarize the novel findings of EV function in various lung diseases, primarily chronic obstructive pulmonary disease (COPD) and lung cancer.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COPD; exosome; extracellular vesicle; lung cancer; mesenchymal stem cell; microRNA

Mesh:

Substances:

Year:  2015        PMID: 26231094     DOI: 10.1016/j.molmed.2015.07.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  67 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

2.  Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo.

Authors:  Duo Zhang; Heedoo Lee; Ziwen Zhu; Jasleen K Minhas; Yang Jin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-11-23       Impact factor: 5.464

3.  Secretory Inositol Polyphosphate 4-Phosphatase Protects against Airway Inflammation and Remodeling.

Authors:  Kritika Khanna; Rituparna Chaudhuri; Jyotirmoi Aich; Bijay Pattnaik; Lipsa Panda; Y S Prakash; Ulaganathan Mabalirajan; Balaram Ghosh; Anurag Agrawal
Journal:  Am J Respir Cell Mol Biol       Date:  2019-04       Impact factor: 6.914

4.  MicroRNAs as Therapeutic Targets in Lung Disease: Prospects and Challenges.

Authors:  Tadashi Sato; Hario Baskoro; Stephen I Rennard; Kuniaki Seyama; Kazuhisa Takahashi
Journal:  Chronic Obstr Pulm Dis       Date:  2015-12-14

Review 5.  Exosomes in immunoregulation of chronic lung diseases.

Authors:  K P Hough; D Chanda; S R Duncan; V J Thannickal; J S Deshane
Journal:  Allergy       Date:  2016-12-08       Impact factor: 13.146

Review 6.  Clinical significance of blood-based miRNAs as biomarkers of non-small cell lung cancer.

Authors:  Lin Li; Yu Sun; Min Feng; Liang Wang; Jing Liu
Journal:  Oncol Lett       Date:  2018-04-12       Impact factor: 2.967

Review 7.  Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis.

Authors:  Brielle A Parris; Hannah E O'Farrell; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 8.  Extracellular vesicles in chronic obstructive pulmonary disease (COPD).

Authors:  Hannah E O'Farrell; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 9.  New Technologies for Analysis of Extracellular Vesicles.

Authors:  Huilin Shao; Hyungsoon Im; Cesar M Castro; Xandra Breakefield; Ralph Weissleder; Hakho Lee
Journal:  Chem Rev       Date:  2018-01-31       Impact factor: 60.622

10.  Therapeutic Effects of Hyaluronic Acid Against Cytotoxic Extracellular Vesicles Released During Pseudomonas Aeruginosa Pneumonia.

Authors:  Yoshifumi Naito; Hideya Kato; Li Zhou; Shinji Sugita; Hongli He; Justin Zheng; Qi Hao; Teiji Sawa; Jae-Woo Lee
Journal:  Shock       Date:  2022-03-01       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.